BackApexigen Overview
Apexigen Inc

Apexigen Return on Equity

Latest ROE for Apexigen: 11.48% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

1148.14%

Return on Equity

1148.14%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Apexigen (APGN) FAQ

Apexigen (APGN) currently reports a ROE of 11.48%. That is above the sector sector average of -4.03%. Use the charts on this page to explore Apexigen's ROE history and peer comparisons.

Apexigen's ROE of 11.48% is higher than the its sector sector average of -4.03%. That is roughly 28625.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Apexigen's current 11.48% should be judged against industry norms (sector average: -4.03%) and against APGN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 11.48%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.03%. From there, open related valuation or income-statement pages for Apexigen, and consider following APGN for alerts when major investors trade the stock.